FdaApplication
ANDA 211220
Identifiers
- fda_app_no: ANDA211220
Properties
| Property | Value |
|---|---|
| applicant_name | NANOMI BV |
| application_type | ANDA |
| approval_date | 2025-09-02 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISPERIDONE | RISPERIDONE | 37.5MG/VIAL | POWDER;INTRAMUSCULAR |
| RISPERIDONE | RISPERIDONE | 50MG/VIAL | POWDER;INTRAMUSCULAR |
| RISPERIDONE | RISPERIDONE | 25MG/VIAL | POWDER;INTRAMUSCULAR |
3 products